UW experts, biotech firm join efforts against colorblindness

News Archive

UW experts, biotech firm join efforts against colorblindness

Agreement involves gene-therapy breakthrough developed in Seattle

The University of Washington signed a licensing agreement with California-based Avalanche Biotechnologies to pursue a therapy for colorblindness, which affects more than 10 million people in the United States. 

Color-vision experts Jay and Maureen Neitz, UW professors of ophthalmology, developed the breakthrough gene-therapy approach in their work with squirrel monkeys.